HIV & AIDS

Special antibodies could lead to HIV vaccine

Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the ...

Diseases, Conditions, Syndromes

Broadly acting antibodies found in plasma of Ebola survivors

Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly ...

HIV & AIDS

Study establishes benchmarks for HIV vaccine candidates

The development of a vaccine that protects against HIV infections has proven extraordinarily difficult. One of the reasons is that naïve precursor B cells that can give rise to mature B cells producing broadly neutralizing ...

page 1 from 5